We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
FDA and Industry Happenings.
- Abstract
The article offers medical research news briefs. The United States Food and Drug Administration have approved the NexStent carotid stent and monorail delivery system manufactured by EndoTex. The TriActive embolic protection system for carotid stenting procedures will be evaluated in a 300-400 patient multi-center trial. Cordis/Johnson and Johnson is set to acquire Conor Medsystems for $1.4 billion.
- Subjects
WORLD news briefs; UNITED States. Food &; Drug Administration; SURGICAL stents; ENDOTEX Interventional Systems Inc.; CONOR Medsystems LLC; MERGERS &; acquisitions
- Publication
Journal of Interventional Cardiology, 2007, Vol 20, Issue 2, p176
- ISSN
0896-4327
- Publication type
Article
- DOI
10.1111/j.1540-8183.2007.00249.x